![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2003, Cell Stress Society International Bacterial stimulation upregulates the surface expression of the stress protein gp96 on B cells in the frog Xenopus Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA *The first 2 authors contributed equally to this study Correspondence to: Jacques Robert, Tel: 585 274-5359; Fax: 585 473-9573; robert/at/mail.rochester.edu Received April 8, 2003; Revised May 20, 2003; Accepted May 28, 2003. This article has been cited by other articles in PMC.Abstract The presence of the soluble intracellular heat shock protein gp96 (an endoplasmic reticulum resident protein) at the surface of certain cell types is an intriguing phenomenon whose physiological significance has been unclear. We have shown that the active surface expression of gp96 by some immune cells is found throughout the vertebrate phylum including the Agnatha, the only vertebrate taxon whose members (lamprey, hagfish) lack an adaptive immune system. To determine whether gp96 surface expression can be modulated by pathogens, we investigated the effects of in vitro stimulation by purified lipopolysaccharide (LPS) and the heat-killed gram-negative bacteria, Escherischia coli and Aeromonas hydrophilia. Purified Xenopus B cells are readily activated and markedly proliferate in vitro in response to the heat-killed bacteria but not to purified LPS. Furthermore, messenger ribonucleic acid, and intracellular and surface protein expressions of both gp96 and immunoglobulin were upregulated only after activation of B cells by heat-killed bacteria. These data are consistent with an ancestral immunological role of gp96 as an antigen-presenting or danger-signaling molecule, or both, interacting directly with antigen-presenting cells, T cells, or natural killer cells, (or all), to trigger or amplify immune responses. INTRODUCTION Upregulation of heat shock or stress proteins (Hsp) is a response shared by all types of cells, from those of prokaryotes to those of eukaryotes, to face various environmental stressors including infection. The importance of this type of response is illustrated by the high degree of phylogenetic conservation of members within each Hsp family. For example, the overall amino acid similarity among Hsp90 members is greater than 50% (Gupta 1995; Nicchitta 1998). In mammals and in the frog Xenopus, Hsps are involved in activation of the adaptive as well as the innate immune systems (review in Srivastava 2002; Robert 2003). Specifically, antigenic peptides chaperoned by Hsps stimulate potent T-cell responses after they undergo receptor-mediated endocytosis by antigen-presenting cells (APCs) and representation by APC's major histocompatibility complex (MHC) class I (Suto and Srivastava 1995; Binder et al 2000a). Hsps also induce an innate type of response (eg, secretion of tumor necrosis factor–α and interleukin-1β [Basu et al 2000]) in an antigenic peptide-independent manner. Several studies suggest that because of their abundance, Hsps are the major protein species released into the extracellular milieu by cell necrosis but not by apoptosis (Basu et al 2000; Binder et al 2000b; Lehner et al 2000). Thus, Hsps associated with nonprogrammed cell death resulting from viral infection and cancer may be considered a “danger” signal (Matzinger 1994). Gp96, a member of the Hsp90 family, is the major resident protein of the endoplasmic reticulum (ER) (review in Csermeley et al 1998). Like other ER-resident proteins, gp96 contains a KDEL (Lys-Asp-Glu-Leu) motif at its carboxyl terminus, which is a retention-retrieval signal from the golgi to the ER (Koch et al 1986; Peter et al 1992). We have shown in the frog Xenopus that even though gp96 contains the ER-retention motif, it is actively expressed at the surface of a subset of immunoglobulin IgM+ B cells and several lymphoid tumor cell lines by an active process involving vesicular trafficking (Robert et al 1999). This phenomenon is relatively cell type specific because surface gp96 is undetectable on nontransformed Xenopus erythrocytes, splenic and peritoneal macrophages, and fibroblasts. We have found a similar gp96 surface expression on some, but not all, catfish lymphoid lines and on lymphocytelike cells of the Pacific hagfish (Robert et al 1999). In mice, surface expression of gp96 has been observed in various tumor cells (Altmeyer et al 1996), lipopolysaccharide (LPS)-stimulated B cells (Banerjee et al 2002), and a subset of murine immature thymocytes (Wiest et al 1997) but not in normal embryonic fibroblasts (Altmeyer et al 1996). Some in vitro evidence suggests that gp96 expressed at the surface of LPS-stimulated murine B cells may activate Th2 cells (Banerjee et al 2002). Furthermore, the physical interaction of gp96 with a Toll-like receptor (TLR) of a B cell line was described in mice (Randow and Seed 2001), suggesting the possibility of surface coexpression of gp96-TLR complex. Altogether, these observations are consistent with the idea that gp96 surface expression may play a role in immune surveillance. The objective of this study was to investigate the modality of surface expression of gp96 by Xenopus B cells that are stimulated with LPS and heat-killed gram-negative bacteria (Escherischia coli, Aeromonas hydrophila). Our results reveal that intracellular and surface expression of gp96 is upregulated by such stimulation. MATERIALS AND METHODS Animals Adult (2–3 year old) outbred Xenopus were either obtained from our breeding colony or purchased from Xenopus I (Dexter, MI, USA). B-cell purification and stimulation B cells from each outbred animal were positively selected with the Xenopus-specific anti-IgM 10A9 monoclonal antibody (mAb) (Hsu and Du Pasquier 1984) and magnetic microbeads (MACS; Miltenyi Biotec, Auburn, CA, USA) coupled with mouse-specific anti-IgG following the manufacturer's instructions. Cells from each animal were grown separately in 24-well plates (1 to 2 × 106 cells/2 mL/well) and were incubated for 1–6 days with LPS (1–100 μg/mL; E coli serotype 0111:B4, Sigma L4130) or with heat-killed bacteria. E coli (XL1-blue, Stratagen, La Jolla, CA, USA) cultured overnight at 37°C and A hydrophilia (ATCC 7965) cultured for 7 days at room temperature were boiled for 30 minutes, spun, and resuspended in 0.1 volume of Xenopus cell culture medium (Robert and Du Pasquier 1996). B cells were stimulated with the equivalent of 1 × 108 to 1 × 106 bacteria/mL of culture (1–100 μg protein/mL). Flow cytometry Total or selected lymphocytes (105 cells) were stained with 1 μg/mL of purified Xenopus-specific biotinylated mAb followed by phycoerythrin (PE)-conjugated or fluorescein isothiocyanate (FITC)–conjugated streptavidin (Pharmagen, San Diego, CA, USA). The following mAb reagents were used: biotinylated anti-CD8 (AM22; Flajnik et al 1991) and IgM (6.16, Bleicher and Cohen 1981); the stained cells were then analyzed by flow cytometry on a FACSCalibur; 10 000 events were collected.Cell surface biotinylation Cells were biotinylated as already published (Robert and Du Pasquier 1996; Robert et al 1999) with sulfosuccinimidyl-6-(biotiamido) Hexanoate (NHS-LC-biotin) (0.5 mg/mL)–amphibian phosphate buffered saline (APBS) solution and incubated for 30 minutes. The biotinylation reaction was stopped by washing 3 times with Lys-APBS. Cells were then lysed for 20 minutes with NP-40 lysis detergent and treated with rat anti-gp96 mAb (SPA-850, StressGen Biotechnologies, Victoria, British Columbia, Canada) and rabbit anti-rat IgG secondary antibody and immunoperecipitated with protein G. For control purposes, IgM was precipitated with the Xenopus-specific anti-IgM 10A9 mAb (Hsu and Du Pasquier 1984). Total amount of protein was determined by a colorimetric method (Bicinchoninic acid [BCA]; Pierce, Rockford, IL, USA). Reverse transcriptase–polymerase chain reaction Cytoplasmic ribonucleic acid (RNA) and first-strand complementary deoxyribonucleic acids (cDNAs) were prepared as previously published (Robert et al 2001b). For each polymerase chain reaction (PCR) (30 μL total volume), 3 μL of 1.25 mM diethylnitrophyenyl thiophosphates, 3 μL of 10× PCR buffer, 1 μL of each primer, 2 U of Taq DNA polymerase (Life Technologies, Grand Island, NY, USA), and 1 μL of cDNAs were used. Tubes were then set for 35 cycles of denaturation for 45 seconds at 95°C, annealing for 45 seconds at 56°C, and extension for 10 minutes at 72°C. Xenopus-specific primers were: gp96 5′-GTTGTAAGCAGGGAAGAGG-3′ and 5′-TGTCTCAGTCTTGCTGCTCCACAC-3′ (277 bp); Cμ 5′-GCAATGCCAAACACCTGG-3′ and TCTT 5′-CTCTTGTAAGGAACCCG-3′ (350 bp); elongation factor-a 5′-CCTGAATCACCCAGGCCAGATTGGTG-3′ and 5′-GAGGGTAGTCTGA GAAGCTCTCCACG-3′ (223 bp). RESULTS Stimulation of B cells by purified LPS, E coli, and A hydrophila Compared with mammals, Xenopus B cells are only poorly reactive in vitro to purified LPS (Bleicher et al 1983). Therefore, we determined whether a whole-bacteria extract might provide better stimulation (eg, blast formation, proliferation). Splenic IgM+ B cells were purified from naive outbreds by magnetic sorting using the Xenopus-specific anti-IgM mAb 10A9 and anti-mouse Ig-conjugated microbeads. As determined by flow cytometry using another anti-IgM mAb (6.16; Fig 1
To substantiate these observations, in vitro proliferation, assayed by tritiated thymidine incorporation, was then performed on positively selected B cells with various amounts of antigens. B cells proliferated promptly (ie, significant DNA synthesis after only 2 days in culture) and steadily in response to killed A hydrophila and E coli. Thymidine incorporation assays also confirmed that Xenopus B cells were poorly responsive to LPS, as has already been published (Bleicher et al 1983). To test whether stimulation by killed bacteria was an indirect effect mediated by macrophages or other APCs, adherent cells were removed by incubation for 1 hour on plastic dishes before purifying B cells. Removal of adherent cells did not significantly affect the B cell response to heat-killed bacteria. In contrast, spleen cells depleted of B cells showed only minimal thymidine incorporation (about 10 times less, Fig 2B Effects of in vitro stimulation on gp96 expression Given a reliable system to reproducibly and markedly stimulate B cells in vitro, we assessed gp96 surface expression on activated B cells by cell surface labeling and immunoprecipitation. Purified B cells, cultured in the presence of heat-killed E coli for 5–6 days, were surface biotinylated, and gp96 was immunoprecipitated with an anti-gp96 rat mAb. A major protein of ~100 kDa (the expected size of the gp96 monomer) was observed in samples incubated with anti-gp96 mAb but not in controls incubated with normal rat IgG (Fig 3A
To determine the total amount of gp96 (surface biotinylated and nonbiotinylated intracellular gp96), the membranes were washed and reprobed with anti-gp96 followed by a horseradish peroxidase (HRP)-conjugated rabbit anti-rat secondary antibody (Robert et al 1999). On stimulation of B cells, the total amount of gp96 also increased, in similar fashion to surface gp96 (Fig 3A To further determine whether B cells exposed to heat-killed bacteria were also upregulating gp96 gene expression, the level of gp96 messenger RNA (mRNA) was determined by reverse transcriptase–polymerase chain reaction. Indeed, a higher amount of gp96 transcript was detected in B cells cultured for 5 days in the presence of heat-killed E coli or 50 μg/mL of LPS compared with cells cultured in medium alone. Moreover, on stimulation of B cells with E coli (Fig 4
DISCUSSION It is not clear why in Xenopus, LPS is not as effective as heat-killed E coli or A hydrophilia in activating B cells. It is possible that the modest responses obtained only at high concentrations of LPS (≥50 μg/mL) are in fact due to a contaminant (eg, lipoprotein) as already reported (Bleicher et al 1983). This would imply that Xenopus B cells are somehow defective in their LPS receptor. Poor responsiveness of Xenopus is further exemplified by the observation that intraperitoneal injection of 0.5 mg of LPS, which would be lethal for a human or a mouse, is well tolerated by Xenopus tadpoles and adults (Robert 2003). In any case, reliable and potent stimulation was obtained with heat-killed bacteria, providing a convenient way to investigate the expression modality of gp96. LPS stimulation of mouse B cells induces gp96 surface expression, and as a result, activates Th2 cells (Banerjee et al 2002). Our data indicate that in Xenopus, stimulating B cells with heat-killed bacteria also markedly increases (10–50-fold) the amount of gp96 present at their cell surface over several days. Surface gp96 upregulation already occurs after an overnight stimulation, suggesting a rapid modulation without an absolute requirement for cell proliferation. Although we do not know whether all B cells or only a subset are upregulating surface gp96, these data suggest that an overall increased fraction of the intracellular fraction of gp96 is accessing the extracellular compartment in response to bacterial stimulation. Although our results indicate that B cells stimulated for 6 days by heat-killed bacteria and LPS also upregulate gp96 gene expression, a more detailed study is needed to determine the association of this phenomenon, if any, with gp96 surface upregulation. It has been proposed that by virtue of their abundance, Hsps are the major protein species released in the extracellular compartment when cells die by necrosis but not by apoptosis (Melcher et al 1998; Basu et al 2000; Berwin et al 2001). According to this view, Hsps could be a “danger signal” (Matzinger 1994) associated with nonprogrammed cell death that occurs in viral infection or cancer. In Xenopus, increased gp96 was found at the surface of stimulated B cells but not in the culture medium (ie, no active secretion or necrosis). Given the dual ability of gp96 to chaperone antigenic peptides and to stimulate innate immune responses in Xenopus (Robert et al 2001a, 2002) as well as in mice (Basu et al 2000; Binder et al 2000b; Lehner et al 2000), elevated expression of surface gp96 induced by bacteria may play a role in immune surveillance by allowing B cells to trigger or enhance immune responses. Immunomodulation by surface gp96 has been obtained with transformed cells that express recombinant gp96 targeted to the cell surface by the addition of a transmembrane domain (Zheng et al 2001); these gp96 surface-positive tumor cells induced efficient dendritic cell maturation after cell-to-cell contact. Therefore, increased gp96 surface expression by activated immune cells may constitute a way other than necrosis to expose APC or T cells to Hsps. In this regard, it is tempting to speculate that surface gp96 may directly interact with receptors on the surface of other cells like T cells or APCs. In mammals, the uptake of gp96-peptide complexes is mediated by CD91, the receptor for α2-macroglobulin (Basu et al 2001; Binder et al 2000a). Once we complete our characterization of the putative CD91 homologue in Xenopus (Robert et al, in preparation), we will be in an excellent position to fully test this hypothesis. Acknowledgments The expert animal husbandry provided by David Albright is gratefully appreciated. This research was supported by RO1 grants AI-44011 and CA-76312 from the NIH, and MCB-0136536 and an IRCEB grant from the NSF. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Mol Biol Evol. 1995 Nov; 12(6):1063-73.
[Mol Biol Evol. 1995]Curr Opin Immunol. 1998 Feb; 10(1):103-9.
[Curr Opin Immunol. 1998]Annu Rev Immunol. 2002; 20():395-425.
[Annu Rev Immunol. 2002]Dev Comp Immunol. 2003 Jun-Jul; 27(6-7):449-64.
[Dev Comp Immunol. 2003]Science. 1995 Sep 15; 269(5230):1585-8.
[Science. 1995]Int Immunol. 2000 Nov; 12(11):1539-46.
[Int Immunol. 2000]Eur J Immunol. 2000 Feb; 30(2):594-603.
[Eur J Immunol. 2000]Pharmacol Ther. 1998 Aug; 79(2):129-68.
[Pharmacol Ther. 1998]J Cell Sci. 1986 Dec; 86():217-32.
[J Cell Sci. 1986]J Biol Chem. 1992 May 25; 267(15):10631-7.
[J Biol Chem. 1992]J Immunol. 1999 Oct 15; 163(8):4133-9.
[J Immunol. 1999]Int J Cancer. 1996 Aug 22; 69(4):340-9.
[Int J Cancer. 1996]Mol Immunol. 1984 Apr; 21(4):257-70.
[Mol Immunol. 1984]J Immunol. 1981 Oct; 127(4):1549-55.
[J Immunol. 1981]J Immunol. 1999 Oct 15; 163(8):4133-9.
[J Immunol. 1999]Mol Immunol. 1984 Apr; 21(4):257-70.
[Mol Immunol. 1984]Dev Comp Immunol. 1983 Summer; 7(3):483-96.
[Dev Comp Immunol. 1983]Dev Comp Immunol. 1983 Summer; 7(3):483-96.
[Dev Comp Immunol. 1983]J Immunol. 1999 Oct 15; 163(8):4133-9.
[J Immunol. 1999]J Immunol. 1999 Oct 15; 163(8):4133-9.
[J Immunol. 1999]Dev Comp Immunol. 1983 Summer; 7(3):483-96.
[Dev Comp Immunol. 1983]Dev Comp Immunol. 2003 Jun-Jul; 27(6-7):449-64.
[Dev Comp Immunol. 2003]J Immunol. 2002 Oct 1; 169(7):3507-18.
[J Immunol. 2002]Nat Med. 1998 May; 4(5):581-7.
[Nat Med. 1998]Int Immunol. 2000 Nov; 12(11):1539-46.
[Int Immunol. 2000]J Biol Chem. 2001 Jun 15; 276(24):21083-8.
[J Biol Chem. 2001]Annu Rev Immunol. 1994; 12():991-1045.
[Annu Rev Immunol. 1994]J Immunol. 2002 Feb 15; 168(4):1697-703.
[J Immunol. 2002]